PPE Agency

 
PPE20033103.jpg
Beschrijving foto:
29-03-2020 Exterior of Janssen Biologics B.V. initiate.
Janssen Biologics B.V. makes, acquires and markets unique biopharmaceutical drugs.
To prevent a potential pandemic, Johnson & Johnson initiated a project to develop a preventive coronavirus vaccine, Covid19, to potentially protect people from the disease.
In doing so, they build on their leadership position in the development of monoclonal antibodies.
Antibodies are substances that the body produces in response to bacteria, viruses or other foreign substances.
Janssen Biologics' innovative products focus on three main disease categories: cardiovascular and immunological disorders and cancer.

© PPE

Afmetingen: 3212 x 1994 (pixels)
Bestandsgrootte: 1706.3 KB
© PPE Agency

Terug naar pagina